62 results
Page 2 of 4
8-K
EX-10.1
pnu44 fz1qe
7 Nov 22
Carve-out Condensed Consolidated Financial Statements
5:02pm
8-K
EX-10.7
r73lae5zo
7 Nov 22
Carve-out Condensed Consolidated Financial Statements
5:02pm
8-K
EX-10.3
srz07o80nq3s1n
7 Nov 22
Carve-out Condensed Consolidated Financial Statements
5:02pm
8-K
EX-10.6
74l18jn1lj t67rtmgck
7 Nov 22
Carve-out Condensed Consolidated Financial Statements
5:02pm
8-K
EX-10.2
x2pjnk1 qqmbh
7 Nov 22
Carve-out Condensed Consolidated Financial Statements
5:02pm
8-K
EX-10.4
j70yk7 tln98ues1l
7 Nov 22
Carve-out Condensed Consolidated Financial Statements
5:02pm
8-K
EX-10.2
gsj3655h8
2 Nov 22
Entry into a Material Definitive Agreement
8:31am
8-K
EX-10.1
lmh7vzy
2 Nov 22
Entry into a Material Definitive Agreement
8:31am
8-K
EX-10.4
kf6trh
2 Nov 22
Entry into a Material Definitive Agreement
8:31am
8-K
EX-10.3
4sgo5zc1r fi66y
2 Nov 22
Entry into a Material Definitive Agreement
8:31am
8-K
EX-10.1
dvf6zdv3 6jw
27 Oct 22
Ignyte Acquisition Corp. Stockholders Approve Proposed Business Combination with Peak Bio
8:30am
8-K
EX-10.1
us5ck9jo406
28 Sep 22
Regulation FD Disclosure
5:00pm
8-K
EX-10.1
t8ubvvx9eeh mb2p
20 Sep 22
Entry into a Material Definitive Agreement
9:42pm
8-K
EX-10.3
wnj6wwjtsofo4q 3h
29 Apr 22
Peak Bio and Ignyte Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Oncology and Inflammation Company
5:27pm
8-K
EX-10.2
o5q3n2ktbrrk
29 Apr 22
Peak Bio and Ignyte Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Oncology and Inflammation Company
5:27pm
8-K
EX-10.1
jx53x21l
29 Apr 22
Peak Bio and Ignyte Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Oncology and Inflammation Company
5:27pm
8-K
EX-10.1
mj86op 0f
25 Mar 22
Entry into a Material Definitive Agreement
4:15pm
10-K
EX-10.4
x2mrs37sw6d2tiwl0hh
15 Apr 21
Annual report
4:43pm
10-K
EX-10.1
o0ff8lqtq 20px
15 Apr 21
Annual report
4:43pm
10-K
EX-10.5
m8686yckmycm3yc
15 Apr 21
Annual report
4:43pm